![Thomas DiRaimondo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas DiRaimondo
Teknisk/Vetenskaplig/F&U Direktör på
JANUX THERAPEUTICS, INC.
Förmögenhet: 2 M $ per 2026-07-31
Profil
Thomas DiRaimondo is the founder of Sitari Pharma, Inc., founded in 2013.
Dr. DiRaimondo currently holds the position of Chief Scientific Officer at Janux Therapeutics, Inc., starting in 2024.
Education history includes a doctorate from Stanford University and undergraduate and graduate degrees from the University of Michigan.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC. 0,18 % | 2026-02-15 | 106 425 ( 0,18 % ) | 2 M $ | 2026-07-31 |
Aktiva positioner av Thomas DiRaimondo
| Företag | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-05-01 |
Tidigare kända positioner av Thomas DiRaimondo
| Företag | Position | Slut |
|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Grundare | 2019-08-01 |
Thomas DiRaimondos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
29
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
